Streetbeat News

Price Targets

TSX:AC

RBC Capital analyst Walter Spracklin has maintained a 'Sector Perform' rating on Air Canada (TSX:AC) but lowered the price target from C$21 to C$17.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:53 pm

SRPT

Cantor Fitzgerald analyst Kristen Kluska has downgraded Sarepta Therapeutics (NASDAQ:SRPT) from Overweight to Neutral and lowered the price target from $166 to $40.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:51 pm

ON

Goldman Sachs analyst Toshiya Hari maintains a Buy rating on ON Semiconductor (NASDAQ:ON) but has lowered the price target from $106 to $93.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:50 pm

OLN

Goldman Sachs analyst Duffy Fischer has maintained a Neutral rating on Olin (NYSE:OLN) and lowered the price target from $57 to $50.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:47 pm

VFC

BMO Capital analyst Simeon Siegel has maintained a 'Market Perform' rating on VF Corporation (NYSE:VFC) but lowered the price target from $22 to $18.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:46 pm

OKTA

Goldman Sachs analyst Gabriela Borges has maintained a 'Buy' rating on Okta (NASDAQ:OKTA) but lowered the price target from $100 to $88.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:45 pm

JKS

Goldman Sachs analyst Brian Lee maintains a 'Sell' rating on JinkoSolar Holding Co (NYSE:JKS) but raises the price target from $27 to $30.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:43 pm

CC

Goldman Sachs analyst Duffy Fischer has maintained a Neutral rating on Chemours (NYSE:CC) and lowered the price target from $35 to $30.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:41 pm

CHGG

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on Chegg (NYSE:CHGG) and lowered the price target from $14 to $10.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:39 pm

CLMT

Goldman Sachs analyst Neil Mehta maintains a 'Buy' rating on Calumet Specialty Prods (NASDAQ:CLMT) but lowers the price target from $19 to $17.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:37 pm